JP2023507848A5 - - Google Patents
Info
- Publication number
- JP2023507848A5 JP2023507848A5 JP2022538737A JP2022538737A JP2023507848A5 JP 2023507848 A5 JP2023507848 A5 JP 2023507848A5 JP 2022538737 A JP2022538737 A JP 2022538737A JP 2022538737 A JP2022538737 A JP 2022538737A JP 2023507848 A5 JP2023507848 A5 JP 2023507848A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154757A JP2026001028A (ja) | 2019-12-23 | 2025-09-18 | 癌の治療のための療法 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962952878P | 2019-12-23 | 2019-12-23 | |
| US201962952859P | 2019-12-23 | 2019-12-23 | |
| US62/952,878 | 2019-12-23 | ||
| US62/952,859 | 2019-12-23 | ||
| US202063019857P | 2020-05-04 | 2020-05-04 | |
| US63/019,857 | 2020-05-04 | ||
| US202063021556P | 2020-05-07 | 2020-05-07 | |
| US63/021,556 | 2020-05-07 | ||
| US202063031453P | 2020-05-28 | 2020-05-28 | |
| US63/031,453 | 2020-05-28 | ||
| US202063123581P | 2020-12-10 | 2020-12-10 | |
| US63/123,581 | 2020-12-10 | ||
| PCT/US2020/065873 WO2021133653A1 (en) | 2019-12-23 | 2020-12-18 | Therapy for the treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154757A Division JP2026001028A (ja) | 2019-12-23 | 2025-09-18 | 癌の治療のための療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507848A JP2023507848A (ja) | 2023-02-27 |
| JPWO2021133653A5 JPWO2021133653A5 (https=) | 2023-12-21 |
| JP2023507848A5 true JP2023507848A5 (https=) | 2023-12-21 |
Family
ID=76575359
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538737A Pending JP2023507848A (ja) | 2019-12-23 | 2020-12-18 | 癌の治療のための療法 |
| JP2025154757A Pending JP2026001028A (ja) | 2019-12-23 | 2025-09-18 | 癌の治療のための療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154757A Pending JP2026001028A (ja) | 2019-12-23 | 2025-09-18 | 癌の治療のための療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230056230A1 (https=) |
| EP (1) | EP4081248A4 (https=) |
| JP (2) | JP2023507848A (https=) |
| KR (1) | KR20220119694A (https=) |
| CN (1) | CN114901306A (https=) |
| AU (1) | AU2020412595A1 (https=) |
| BR (1) | BR112022012437A2 (https=) |
| CA (1) | CA3165839A1 (https=) |
| IL (1) | IL294207A (https=) |
| MX (1) | MX2022007790A (https=) |
| TW (1) | TW202138387A (https=) |
| WO (1) | WO2021133653A1 (https=) |
| ZA (1) | ZA202206743B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4106813A4 (en) * | 2020-02-21 | 2024-03-27 | MacroGenics, Inc. | CD137 BINDING MOLECULES AND THEIR USES |
| WO2022087402A1 (en) * | 2020-10-23 | 2022-04-28 | Bristol-Myers Squibb Company | Lag-3 antagonist therapy for lung cancer |
| EP4363449A2 (en) * | 2021-07-02 | 2024-05-08 | Genentech, Inc. | Methods and compositions for treating cancer |
| AU2022317820A1 (en) * | 2021-07-28 | 2023-12-14 | F. Hoffmann-La Roche Ag | Methods and compositions for treating cancer |
| CA3233205A1 (en) * | 2021-09-29 | 2023-04-06 | Yu Xia | Anti-lag3 antibody, pharmaceutical composition and use |
| WO2023066322A1 (zh) * | 2021-10-21 | 2023-04-27 | 杭州阿诺生物医药科技有限公司 | 一种融合多肽及其用途 |
| WO2024051223A1 (zh) * | 2022-09-09 | 2024-03-14 | 中山康方生物医药有限公司 | 药物组合及用途 |
| WO2024163009A1 (en) * | 2023-01-31 | 2024-08-08 | Genentech, Inc. | Methods and compositions for treating urothelial bladder cancer |
| TW202436339A (zh) * | 2023-01-31 | 2024-09-16 | 瑞士商赫孚孟拉羅股份公司 | 治療選自非小細胞肺癌或三陰性乳癌的癌症之用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5998060B2 (ja) * | 2010-03-04 | 2016-09-28 | マクロジェニクス，インコーポレーテッド | Ｂ７−ｈ３と反応性のある抗体、その免疫学的に活性なフラグメントおよびその使用 |
| SG11201601763SA (en) * | 2013-09-20 | 2016-04-28 | Bristol Myers Squibb Co | Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumors |
| TWI693232B (zh) * | 2014-06-26 | 2020-05-11 | 美商宏觀基因股份有限公司 | 與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法 |
| TWI773646B (zh) * | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| WO2017019846A1 (en) * | 2015-07-30 | 2017-02-02 | Macrogenics, Inc. | Pd-1-binding molecules and methods use thereof |
| AU2016307955A1 (en) * | 2015-08-17 | 2018-03-08 | Macrogenics, Inc. | Bispecific monovalent diabodies that are capable of binding B7-H3 and CD3, and uses thereof |
| US10954301B2 (en) * | 2015-12-14 | 2021-03-23 | Macrogenics, Inc. | Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof |
| TWI781098B (zh) * | 2016-04-15 | 2022-10-21 | 美商宏觀基因股份有限公司 | 新穎的ｂ７-ｈ３-結合分子、其抗體藥物綴合物及其使用方法 |
| MX2018014950A (es) * | 2016-06-07 | 2019-04-25 | Macrogenics Inc | Terapia de combinacion. |
| KR102664891B1 (ko) * | 2016-06-20 | 2024-05-13 | 에프-스타 테라퓨틱스 리미티드 | Pd-l1 및 lag-3에 결합하는 결합 분자 |
| CN111315776A (zh) * | 2017-03-29 | 2020-06-19 | 葛莱高托普有限公司 | Pd-l1和ta-muc1抗体 |
| TWI690538B (zh) * | 2017-04-05 | 2020-04-11 | 瑞士商赫孚孟拉羅股份公司 | 特異性結合至pd1至lag3的雙特異性抗體 |
| EP3630179A2 (en) * | 2017-05-30 | 2020-04-08 | Bristol-Myers Squibb Company | Compositions comprising an anti-lag-3 antibody or an anti-lag-3 antibody and an anti-pd-1 or anti-pd-l1 antibody |
| WO2019148412A1 (en) * | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| WO2019179422A1 (en) * | 2018-03-20 | 2019-09-26 | Wuxi Biologics (Shanghai) Co., Ltd. | Novel bispecific pd-1/lag-3 antibody molecules |
-
2020
- 2020-12-18 BR BR112022012437A patent/BR112022012437A2/pt unknown
- 2020-12-18 CN CN202080090186.8A patent/CN114901306A/zh active Pending
- 2020-12-18 AU AU2020412595A patent/AU2020412595A1/en active Pending
- 2020-12-18 IL IL294207A patent/IL294207A/en unknown
- 2020-12-18 US US17/787,793 patent/US20230056230A1/en active Pending
- 2020-12-18 WO PCT/US2020/065873 patent/WO2021133653A1/en not_active Ceased
- 2020-12-18 CA CA3165839A patent/CA3165839A1/en active Pending
- 2020-12-18 MX MX2022007790A patent/MX2022007790A/es unknown
- 2020-12-18 EP EP20906153.0A patent/EP4081248A4/en active Pending
- 2020-12-18 KR KR1020227025578A patent/KR20220119694A/ko active Pending
- 2020-12-18 JP JP2022538737A patent/JP2023507848A/ja active Pending
- 2020-12-22 TW TW109145572A patent/TW202138387A/zh unknown
-
2022
- 2022-06-17 ZA ZA2022/06743A patent/ZA202206743B/en unknown
-
2025
- 2025-09-18 JP JP2025154757A patent/JP2026001028A/ja active Pending